Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients

Background: Measurable/minimal residual disease (MRD) status is suggested as a powerful indicator of clinical-outcome in T-cell lymphoblastic leukemia/lymphoma (T-ALL). Contrary to B-cell ALL, reports on T-ALL MRD are limited and mostly based on molecular methods, mainly from developed countries. Mu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Tembhare, Prashant R., Narula, Gaurav, Khanka, Twinkle, Ghogale, Sitaram, Chatterjee, Gaurav, Patkar, Nikhil V., Prasad, Maya, Badrinath, Yajamanam, Deshpande, Nilesh, Gudapati, Pratyusha, Verma, Shefali, Sanyal, Mahima, Kunjachan, Florence, Mangang, Gunit, Gujral, Sumeet, Banavali, Shripad, Subramanian, Papagudi G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7193086/
https://ncbi.nlm.nih.gov/pubmed/32391267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00577
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia